New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial
Shares of Magenta Therapeutics (NASDAQ: MGTA) declined 22% on June [...]
Shares of Magenta Therapeutics (NASDAQ: MGTA) declined 22% on June [...]
Magenta Therapeutics (NASDAQ: MGTA), which is developing stem cell transplant [...]
$MGTA Probability Sentiment SUMMARY SanaCurrents [...]